Farther Finance Advisors’s LENZ Therapeutics LENZ Stock Holding History

Farther Finance Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$972	Sell	253 -342	-57%	-$1.7K	﹤0.01%	5595
2026 Q2	$3.38K	Buy	595 +258	+77%	+$2.08K	﹤0.01%	4979
2026 Q1	$3.15K	Sell	337 -159	-32%	-$2.23K	﹤0.01%	4715
2025 Q4	$7.94K	Buy	496 +356	+254%	+$10.4K	﹤0.01%	4062
2025 Q3	$6.52K	Buy	+140	New	+$5.15K	﹤0.01%	3647

Other funds holding LENZ

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's LENZ Position: Q3 2026 in Review

Farther Finance Advisors reduced its LENZ Therapeutics (LENZ) stake by 57% in Q3 2026, selling an estimated $1.7K and leaving 253 shares worth $972. The position accounts for ﹤0.01% of the portfolio, ranked #5595.

Farther Finance Advisors first reported a position in LENZ in Q3 2025 and has held it in 5 quarters since. The position peaked at $7.94K in Q4 2025. 5 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

Farther Finance Advisors held 253 shares of LENZ Therapeutics worth $972 as of Q3 2026.
Farther Finance Advisors sold 342 LENZ Therapeutics shares in Q3 2026, an estimated $1.7K.
LENZ Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5595 holding.
Farther Finance Advisors first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's LENZ Therapeutics position peaked at $7.94K in Q4 2025.
5 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.